Jia-Hwa Fang, Ph.D., has joined SRI's biosciences division as director of clinical manufacturing. In this new role, he will lead a team to transfer and scale-up R&D, Good Laboratory Practice (GLP), and pilot formulations for early stage clinical
trial materials in compliance with Good Manufacturing Practices (GMP). He will be responsible for developing technical, quality, and project specifications for studies in SRI's pharmaceutical clinical manufacturing facility.

Fang has more than 20 years industry experiences at small and large biotech companies. Prior to joining SRI, he was a consultant for Impax Laboratories.